Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis
Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the efficacy and dose-effect relationship of X842
capsules at different dosages in the treatment of reflux esophagitis for 4 weeks in
comparison with lansoprazole enteric-coated capsules.